CD95 is not functional in human erythrocytes

被引:8
|
作者
Sagan, D. [1 ]
Jermnim, N. [1 ]
Tangvarasittichai, O. [1 ]
机构
[1] Naresuan Univ, Fac Allied Hlth Sci, Phitsanulok 65000, Thailand
关键词
CD95; apoptosis; eryptosis; erythrocyte phosphatidylserine; exposure; PHOSPHATIDYLSERINE EXTERNALIZATION; APOPTOSIS; CELLS; MECHANISMS; EXPRESSION; ERYPTOSIS; CASPASE-3; LIGATION; PATHWAY; DEATH;
D O I
10.1111/j.1751-553X.2010.01245.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The CD95 pathway is a potent inducer of apoptosis in nucleated cells and this death receptor is important for proper blood cell development. Although it is expressed in red blood cells, its functional role in erythrocytes is not well documented. These anucleated cells can undergo cell death via eryptosis, a process showing similarities to apoptosis of nucleated cells. This mode of cell death is mainly triggered by oxidative stress or energy depletion. Methods: CH11 was added to the purified human erythrocytes for induction of phosphatidylserine (PS) exposure. AnnexinV-FITC was used as a probe for PS detection. Results: No significantly enhanced PS-positive cell fraction could be observed after erythrocytes were treated with CH11. Conclusion: Based on some key features for an activated CD95 system, this death receptor has been considered to induce PS exposure. However, we give evidence, that CD95 is not functional in red blood cells and that activation of this death receptor does not lead to the exposure of phosphatidylserine.
引用
收藏
页码:E244 / E247
页数:4
相关论文
共 50 条
  • [41] Principles and mechanisms of CD95 activation
    Wajant, Harald
    BIOLOGICAL CHEMISTRY, 2014, 395 (12) : 1401 - 1416
  • [42] CD95 Signaling in Cancer Treatment
    De la Rosa, Angel J.
    Gomez, Miguel A.
    Morales, Salvador
    Padillo, Francisco J.
    Muntane, Jordi
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (17) : 2809 - 2818
  • [43] Combination of Human Fas (CD95/Apo-1) Ligand with Adriamycin Significantly Enhances the Efficacy of Antitumor Response
    Liu, Zhongchen
    Liu, Ruizhen
    Qiu, Jinhua
    Yin, Ping
    Luo, Fanghong
    Su, Jinhua
    Li, Wenzhu
    Chen, Caixia
    Fan, Xin
    Zhang, Jiakai
    Zhuang, Guohong
    CELLULAR & MOLECULAR IMMUNOLOGY, 2009, 6 (03) : 167 - 174
  • [44] Modulation of CD4+ T-cell activation by CD95 co-stimulation
    Paulsen, M.
    Valentin, S.
    Mathew, B.
    Adam-Klages, S.
    Bertsch, U.
    Lavrik, I.
    Krammer, P. H.
    Kabelitz, D.
    Janssen, O.
    CELL DEATH AND DIFFERENTIATION, 2011, 18 (04) : 619 - 631
  • [45] CD95 ligand-induced apoptosis of human medulloblastoma cells
    Weller, M
    Schuster, M
    Pietsch, T
    Schabet, M
    CANCER LETTERS, 1998, 128 (02) : 121 - 126
  • [46] The CD95/CD95L signaling pathway: A role in carcinogenesis
    Fouque, Arnelie
    Debure, Laure
    Legembre, Patrick
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1846 (01): : 130 - 141
  • [47] Identification, characterisation and regulation by CD40 activation of novel CD95 splice variants in CD95-apoptosis-resistant, human, B-cell non-Hodgkin's lymphoma
    Lajmanovich, Alicia
    Ribeyron, Juliana Bruder
    Florin, Anne
    Fournier, Alexandra
    Pasquier, Marie-Anne
    Duley, Samuel
    Chauvet, Martine
    Plumas, Joel
    Bonnefoix, Thierry
    Gressin, Remy
    Leroux, Dominique
    Callanan, Mary B.
    EXPERIMENTAL CELL RESEARCH, 2009, 315 (19) : 3281 - 3293
  • [48] Mycobacterial formulation in liposomes showed decreased expression of CD95/CD95L and caspase activity in T cells of leprosy patients
    Bisht, V
    Chattree, V
    Khanna, N
    Rao, DN
    CURRENT APPLIED PHYSICS, 2005, 5 (02) : 189 - 193
  • [49] APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo
    Eisele, Guenter
    Roth, Patrick
    Hasenbach, Kathy
    Aulwurm, Steffen
    Wolpert, Fabian
    Tabatabai, Ghazaleh
    Wick, Wolfgang
    Weller, Michael
    NEURO-ONCOLOGY, 2011, 13 (02) : 155 - 164
  • [50] Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils
    Luttmann, W
    Opfer, A
    Dauer, E
    Foerster, M
    Matthys, H
    Eibel, H
    Schulze-Osthoff, K
    Kroegel, C
    Virchow, JC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (07) : 2057 - 2065